Ameriprise’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Ameriprise’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,610	Closed	-$129K	–	4064
2021 Q3	$129K	Sell	5,610 -1,827	-25%	-$54.4K	﹤0.01%	3761
2021 Q2	$327K	Buy	7,437 +667	+10%	+$37.2K	﹤0.01%	3607
2021 Q1	$491K	Sell	6,770 -1,258	-16%	-$89.4K	﹤0.01%	3408
2020 Q4	$347K	Sell	8,028 -276	-3%	-$12.4K	﹤0.01%	3460
2020 Q3	$342K	Buy	8,304 +1,355	+19%	+$70K	﹤0.01%	3384
2020 Q2	$417K	Buy	+6,949	New	+$637K	﹤0.01%	3252

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Ameriprise's ORTX Position: Q4 2021 in Review

Ameriprise sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 5,610 shares — an estimated $129K sold.

Ameriprise first reported a position in ORTX in Q2 2020 and held it in 6 quarters. The position peaked at $491K in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

Ameriprise reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Ameriprise sold 5,610 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $129K.
Ameriprise first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2020 and held it in 6 quarters.
Ameriprise's Orchard Therapeutics plc American Depositary Shares position peaked at $491K in Q1 2021.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Ameriprise's 13F filing for Q4 2021, filed 14 Feb 2022.